ISTHMIN-1 and SPEXIN as PROMISING NOVEL BIOMARKER CANDIDATES for INVASIVE DUCTAL BREAST CARCINOMA

Ahmet Turk,Tuba Ozcan Metin,Tuncay Kuloglu,Mustafa Yilmaz,Gokhan Artas,I. Hanifi Ozercan,Serhat Hancer
DOI: https://doi.org/10.1016/j.tice.2024.102601
IF: 2.586
2024-11-05
Tissue and Cell
Abstract:Introduction Breast cancer is one of the most common malignant tumors and a leading cause of cancer-related death in women. Research is focusing on biomarkers linked to breast cancer, particularly two novel proteins: isthmin-1 (ISM-1) and spexin (SPX), which require further investigation. Material and Methods The study involved 20 healthy controls and 60 patients with invasive ductal carcinoma, categorized into three groups: Grade I (n=20), Grade II (n=20), and Grade III (n=20). Levels of ISM-1 and SPX in tissue were analyzed using immunohistochemistry alongside the clinicopathologic data of patients. Results There were no statistically significant differences in age, menopausal status, ER, PR, and Cerb-B2 values across grades (p>0.05). Tumor diameters showed a significant increase in Grade I compared to Grade II (p<0.05), while no significant difference was noted between Grade II and Grade III, although diameters were larger in Grade III compared to Grade I (p<0.05). Notably, ISM-1 immunoreactivity decreased, and SPX immunoreactivity increased significantly across all grades compared to normal tissue (p 0.05). Conclusions This study presents new findings on ISM-1 and SPX expression in invasive ductal breast carcinoma. The decrease in ISM-1 and increase in SPX suggest a need for further research into the relationship between adipokines and tumor development in breast cancer.
cell biology,anatomy & morphology
What problem does this paper attempt to address?